InvestorsHub Logo
Followers 22
Posts 4021
Boards Moderated 0
Alias Born 10/12/2013

Re: ralphey post# 328746

Wednesday, 03/10/2021 6:47:30 PM

Wednesday, March 10, 2021 6:47:30 PM

Post# of 423547

The pharmacy will then be liable for infringement - and therein lies the war of attrition AMRN will need to fight - the problem is no one knows for what indication an MD writes the RX for - thereby allowing infringement to slip in and requiring a lengthy, messy, time consuming and expensive process to eliminate such BUT WAIT ...ALL IS NOT LOST ...ENTER

VASTOR - the new enhanced statin (VAscepa plus a statin) - its clear that it must be for CAD and will be impossible to substitute gV for such without revealing direct infringement -

1.) VASTOR is much easier to market Docs know what a statin is and will be immediately attracted to an ENHANCED STATIN OVER A MODIFIED FISH OIL
2.) Infringement is immediately proven preventing such
3.) AMRN captures vast majority of statin market
4.) Stock price soars




Better idea; Fund an ambulance chaser in each state/major city to chase down prescription/patent cases.

<Call this 1-800 number>
<Is your health being compromised for a big wigs yearly bonus?>
<Are you owed a settlement?>
<Is your insurance company stealing your benefits?>
<Would you like to work with someone else's prepaid big time lawyer?>
<Call this number right now!!!>
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News